Literature DB >> 19794966

A gene expression classifier of node-positive colorectal cancer.

Paul F Meeh1, Christopher L Farrell, Randal Croshaw, Hampton Crimm, Samantha K Miller, Dora Oroian, Sangeeta Kowli, Jinyu Zhu, Wayne Carver, Wensong Wu, Edsel Pena, Phillip J Buckhaults.   

Abstract

We used digital long serial analysis of gene expression to discover gene expression differences between node-negative and node-positive colorectal tumors and developed a multigene classifier able to discriminate between these two tumor types. We prepared and sequenced long serial analysis of gene expression libraries from one node-negative and one node-positive colorectal tumor, sequenced to a depth of 26,060 unique tags, and identified 262 tags significantly differentially expressed between these two tumors (P < 2 x 10(-6)). We confirmed the tag-to-gene assignments and differential expression of 31 genes by quantitative real-time polymerase chain reaction, 12 of which were elevated in the node-positive tumor. We analyzed the expression levels of these 12 upregulated genes in a validation panel of 23 additional tumors and developed an optimized seven-gene logistic regression classifier. The classifier discriminated between node-negative and node-positive tumors with 86% sensitivity and 80% specificity. Receiver operating characteristic analysis of the classifier revealed an area under the curve of 0.86. Experimental manipulation of the function of one classification gene, Fibronectin, caused profound effects on invasion and migration of colorectal cancer cells in vitro. These results suggest that the development of node-positive colorectal cancer occurs in part through elevated epithelial FN1 expression and suggest novel strategies for the diagnosis and treatment of advanced disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19794966      PMCID: PMC2745673          DOI: 10.1593/neo.09808

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  36 in total

1.  Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes.

Authors:  Izidore S Lossos; Debra K Czerwinski; Ash A Alizadeh; Mark A Wechser; Rob Tibshirani; David Botstein; Ronald Levy
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

Review 2.  Fibronectin and its integrin receptors in cancer.

Authors:  E Ruoslahti
Journal:  Adv Cancer Res       Date:  1999       Impact factor: 6.242

3.  Cellular fibronectin expression is down-regulated at the mRNA level in differentiating human intestinal epithelial cells.

Authors:  P H Vachon; A Simoneau; F E Herring-Gillam; J F Beaulieu
Journal:  Exp Cell Res       Date:  1995-01       Impact factor: 3.905

4.  Genomic analysis of metastasis reveals an essential role for RhoC.

Authors:  E A Clark; T R Golub; E S Lander; R O Hynes
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

5.  Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Authors:  P J Morin; A B Sparks; V Korinek; N Barker; H Clevers; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

6.  The Wnt/Wg signal transducer beta-catenin controls fibronectin expression.

Authors:  D Gradl; M Kühl; D Wedlich
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

7.  Secreted and cell surface genes expressed in benign and malignant colorectal tumors.

Authors:  P Buckhaults; C Rago; B St Croix; K E Romans; S Saha; L Zhang; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

8.  Expression of fibronectin and tenascin-C mRNA by myofibroblasts, vascular cells and epithelial cells in human colon adenomas and carcinomas.

Authors:  N Hanamura; T Yoshida; E Matsumoto; Y Kawarada; T Sakakura
Journal:  Int J Cancer       Date:  1997-09-26       Impact factor: 7.396

9.  Inhibition of tumor progression and neoangiogenesis using cyclic RGD-peptides in a chemically induced colon carcinoma in rats.

Authors:  Jörg Haier; Ulrike Goldmann; Birgit Hotz; Norbert Runkel; Ulrich Keilholz
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

10.  Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts.

Authors:  P Pujuguet; A Hammann; M Moutet; J L Samuel; F Martin; M Martin
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

View more
  17 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  p27Kip1 represses the Pitx2-mediated expression of p21Cip1 and regulates DNA replication during cell cycle progression.

Authors:  E Gallastegui; A Biçer; S Orlando; A Besson; M J Pujol; O Bachs
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

3.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

4.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

5.  Network cluster analysis of protein-protein interaction network identified biomarker for early onset colorectal cancer.

Authors:  Tiancheng Luo; Shengdi Wu; Xizhong Shen; Lei Li
Journal:  Mol Biol Rep       Date:  2013-11-07       Impact factor: 2.316

6.  Monocytes conditioned media stimulate fibronectin expression and spreading of inflammatory breast cancer cells in three-dimensional culture: A mechanism mediated by IL-8 signaling pathway.

Authors:  Mona M Mohamed
Journal:  Cell Commun Signal       Date:  2012-02-10       Impact factor: 5.712

7.  Increased expression of PITX2 transcription factor contributes to ovarian cancer progression.

Authors:  Frederic K C Fung; David W Chan; Vincent W S Liu; Thomas H Y Leung; Annie N Y Cheung; Hextan Y S Ngan
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

8.  Paired-like Homeodomain Transcription factor 2 expression by breast cancer bone marrow disseminated tumor cells is associated with early recurrent disease development.

Authors:  Sreeraj G Pillai; Nupur Dasgupta; Chidananda M Siddappa; Mark A Watson; Timothy Fleming; Kathryn Trinkaus; Rebecca Aft
Journal:  Breast Cancer Res Treat       Date:  2015-09-23       Impact factor: 4.872

9.  Robust prediction of anti-cancer drug sensitivity and sensitivity-specific biomarker.

Authors:  Heewon Park; Teppei Shimamura; Satoru Miyano; Seiya Imoto
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

10.  Alterations of gene expression and protein synthesis in co-cultured adipose tissue-derived stem cells and squamous cell-carcinoma cells: consequences for clinical applications.

Authors:  Eva Koellensperger; Felix Gramley; Fabian Preisner; Uwe Leimer; Guenter Germann; Verena Dexheimer
Journal:  Stem Cell Res Ther       Date:  2014-05-12       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.